This is a randomized,controled, phase III, open label study of postoperative concurrent chemoradiotherapy with Docetaxel versus Cisplatinum for high-risk squamous cell carcinoma of the head and neck(HNSCC).The primary purpose of this study is to evaluate the efficacy and safety of concurrent chemoradiotherapy with docetaxel in HNSCC patients.